In this JAMA Health Forum post, KFF’s Larry Levitt outlines four reasons why high drug prices are in the spotlight more than hospital prices, even though hospitals accounted for 40% of the growth in national health spending from 2022 to 2024, and explores the potential for policy action to restrain them.
Disclaimer: This story is auto-aggregated by a computer program and has not been created or edited by lifecarefinanceguide.
Publisher: Source link
Publisher: Source link
